top of page

AMM-Only Project Pioneers Grant Programme 2026: Funding Innovative Research in Duchenne Muscular Dystrophy - Applications Now Open

  • 2 days ago
  • 2 min read

AMM-Only Project, a Monaco-based association dedicated to advancing research in Duchenne muscular dystrophy (DMD) and related neuromuscular diseases, is pleased to announce the opening of applications for the 2026 edition of the Pioneers Grant Programme.

Launched in 2025, the Pioneers Grant Programme was created to accelerate scientific discovery and the development of innovative therapeutic approaches for Duchenne muscular dystrophy and other neuromuscular disorders. The programme supports ambitious, high-risk, high-impact research projects with funding ranging from €500,000 to €2 million.MM-Only Project, a Monaco-based association dedicated to advancing research in Duchenne muscular dystrophy (DMD) and related neuromuscular diseases, is pleased to announce the opening of applications for the 2026 edition of the Pioneers Grant Programme.

Launched in 2025, the Pioneers Grant Programme was created to accelerate scientific discovery and the development of innovative therapeutic approaches for Duchenne muscular dystrophy and other neuromuscular disorders. The programme supports ambitious, high-risk, high-impact research projects with funding ranging from €500,000 to €2 million.


Supporting Groundbreaking Research

The inaugural edition of the programme resulted in the funding of four outstanding projects conducted by leading European research institutions, demonstrating the programme's commitment to fostering transformative advances in the field.

The Pioneers Grant Programme welcomes innovative proposals with the potential to significantly improve the understanding, treatment, and future care of patients affected by neuromuscular diseases.


Who Should Apply?

The programme is intended for researchers and multidisciplinary teams working on cutting-edge scientific and clinical approaches in Duchenne muscular dystrophy and related neuromuscular diseases, including novel gene and cell therapies and other breakthrough therapeutic strategies.


Key Dates

  • Call for applications: Open

  • Expression of Interest deadline: August 2026


Learn More

Researchers interested in applying are encouraged to submit an Expression of Interest before the August 2026 deadline.

For more information and application details, please visit: https://onlyproject.org/applying-for-grants-and-support/


 
 
bottom of page